Markets
Opinion
National
Politics
Companies
Economy
Business
World
Sport
Life
BusinessDay TV
E-Edition
Our Network
23 October 2019
2 Min Read
Eli Lilly’s third-quarter sales miss estimates as rebates crimp profit
in
Companies
/
Healthcare
by
Saumya Joseph and Manas Mishra
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe
Sign In
Related Articles
Companies
Eli Lilly lifts 2019 outlook on demand for newer drugs
Companies
Drug maker Lilly offers half-price insulin in US
Loading ...
Loading ...
View Comments